Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzocaine Lozenge for Sore Throat in URTI
NCT03432923Phase 3Completed
- Sponsor
- McNeil Laboratories
- Start
- Feb 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pharyngitis comparing Benzocaine 8 mg with Placebo (2 arms). Primary endpoint: Time to meaningful pain relief at 3 hours. Started Feb 2018; status: completed.
02
Drugs
benzocaine
03
Conditions
pharyngitis
Beyond the preview
Go deeper on NCT03432923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03432923.